InsiderSource

Stanton Marshall S.

SVP, Clinical & MD Affair · SEC CIK 1849615
Insider at AORT ARTIVION, INC. CRY CRYOLIFE INC
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$6.07M
35 trades
Net flow
−$6.07M
Net selling
Total filings
52
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
AORT
ARTIVION, INC.
Sell Stanton Marshall S. · SVP, Clinical & MD Affair · Open-market sale · filed Mar 4, 2026 ΔOwn −3.5%

Stanton Marshall S. sold $81.2K of AORT, trimming their stake 3%.

−$81.2K
2,149 sh @ $38
AORT
ARTIVION, INC.
Sell Stanton Marshall S. · SVP, Clinical & MD Affair · Open-market sale · filed Mar 3, 2026 ΔOwn −3.6%

Stanton Marshall S. sold $57.5K of AORT, trimming their stake 4%.

−$57.5K
1,513 sh @ $38
AORT
ARTIVION, INC.
Sell Stanton Marshall S. · SVP, Clinical & MD Affair · Open-market sale · filed Feb 25, 2026 ΔOwn −2.9%

Stanton Marshall S. sold $44.9K of AORT, trimming their stake 3%.

−$44.9K
1,259 sh @ $36
AORT
ARTIVION, INC.
Sell Stanton Marshall S. · SVP, Clinical & MD Affair · Open-market sale · filed Feb 25, 2026 ΔOwn −5.3%

Stanton Marshall S. sold $91.1K of AORT, trimming their stake 5%.

−$91.1K
2,423 sh @ $38
Advertisement
AORT
ARTIVION, INC.
Sell Stanton Marshall S. · SVP, Clinical & MD Affair · Open-market sale · filed Nov 24, 2025 ΔOwn −22%

Stanton Marshall S. sold $655.2K of AORT, trimming their stake 22%.

−$655.2K
14,586 sh @ $45
AORT
ARTIVION, INC.
Sell Stanton Marshall S. · SVP, Clinical & MD Affair · Open-market sale · filed Nov 24, 2025 ΔOwn −11%

Stanton Marshall S. sold $259.2K of AORT, trimming their stake 11%.

−$259.2K
5,715 sh @ $45
AORT
ARTIVION, INC.
Sell Stanton Marshall S. · SVP, Clinical & MD Affair · Open-market sale · filed Nov 24, 2025 ΔOwn −26%

Stanton Marshall S. sold $840K of AORT, trimming their stake 26%.

−$840K
18,705 sh @ $45
AORT
ARTIVION, INC.
Sell Stanton Marshall S. · SVP, Clinical & MD Affair · Open-market sale · filed Nov 24, 2025 ΔOwn −16%

Stanton Marshall S. sold $379.5K of AORT, trimming their stake 16%.

−$379.5K
8,370 sh @ $45
AORT
ARTIVION, INC.
Sell Stanton Marshall S. · SVP, Clinical & MD Affair · Open-market sale · filed Nov 24, 2025 ΔOwn −21%

Stanton Marshall S. sold $524.7K of AORT, trimming their stake 21%.

−$524.7K
11,888 sh @ $44
AORT
ARTIVION, INC.
Sell Stanton Marshall S. · SVP, Clinical & MD Affair · Open-market sale · filed Nov 24, 2025 ΔOwn −4.3%

Stanton Marshall S. sold $90.1K of AORT, trimming their stake 4%.

−$90.1K
2,033 sh @ $44
AORT
ARTIVION, INC.
Sell Stanton Marshall S. · SVP, Clinical & MD Affair · Open-market sale · filed Nov 24, 2025 ΔOwn −2.9%

Stanton Marshall S. sold $60K of AORT, trimming their stake 3%.

−$60K
1,355 sh @ $44
AORT
ARTIVION, INC.
Sell Stanton Marshall S. · SVP, Clinical & MD Affair · Open-market sale · filed Nov 14, 2025 ΔOwn −8.1%

Stanton Marshall S. sold $229K of AORT, trimming their stake 8%.

−$229K
4,993 sh @ $46
AORT
ARTIVION, INC.
Sell Stanton Marshall S. · SVP, Clinical & MD Affair · Open-market sale · filed Nov 12, 2025 ΔOwn −4.0%

Stanton Marshall S. sold $114.5K of AORT, trimming their stake 4%.

−$114.5K
2,566 sh @ $45
AORT
ARTIVION, INC.
Sell Stanton Marshall S. · SVP, Clinical & MD Affair · Open-market sale · filed Aug 28, 2025 ΔOwn −22%

Stanton Marshall S. sold $801.2K of AORT, trimming their stake 22%.

−$801.2K
18,200 sh @ $44
AORT
ARTIVION, INC.
Sell Stanton Marshall S. · SVP, Clinical & MD Affair · Open-market sale · filed Jun 18, 2025 ΔOwn −17%

Stanton Marshall S. sold $406K of AORT, trimming their stake 17%.

−$406K
13,764 sh @ $30
AORT
ARTIVION, INC.
Sell Stanton Marshall S. · SVP, Clinical & MD Affair · Open-market sale · filed Jun 18, 2025 ΔOwn −1.9%

Stanton Marshall S. sold $36.5K of AORT, trimming their stake 2%.

−$36.5K
1,236 sh @ $30
AORT
ARTIVION, INC.
Sell Stanton Marshall S. · SVP, Clinical & MD Affair · Open-market sale · filed Jun 16, 2025 ΔOwn −8.3%

Stanton Marshall S. sold $249K of AORT, trimming their stake 8%.

−$249K
8,747 sh @ $28
AORT
ARTIVION, INC.
Sell Stanton Marshall S. · SVP, Clinical & MD Affair · Open-market sale · filed Jun 16, 2025 ΔOwn −1.3%

Stanton Marshall S. sold $35.7K of AORT, trimming their stake 1%.

−$35.7K
1,253 sh @ $28
AORT
ARTIVION, INC.
Sell Stanton Marshall S. · SVP, Clinical & MD Affair · Open-market sale · filed Jun 16, 2025 ΔOwn −15%

Stanton Marshall S. sold $406.6K of AORT, trimming their stake 15%.

−$406.6K
14,306 sh @ $28
AORT
ARTIVION, INC.
Sell Stanton Marshall S. · SVP, Clinical & MD Affair · Open-market sale · filed Jun 16, 2025 ΔOwn −2.3%

Stanton Marshall S. sold $51.9K of AORT, trimming their stake 2%.

−$51.9K
1,826 sh @ $28
AORT
ARTIVION, INC.
Sell Stanton Marshall S. · SVP, Clinical & MD Affair · Open-market sale · filed May 12, 2025 ΔOwn −5.0%

Stanton Marshall S. sold $167.1K of AORT, trimming their stake 5%.

−$167.1K
5,737 sh @ $29
AORT
ARTIVION, INC.
Sell Stanton Marshall S. · SVP, Clinical & MD Affair · Open-market sale · filed May 12, 2025 ΔOwn −4.4%

Stanton Marshall S. sold $140.1K of AORT, trimming their stake 4%.

−$140.1K
4,811 sh @ $29
AORT
ARTIVION, INC.
Sell Stanton Marshall S. · SVP, Clinical & MD Affair · Open-market sale · filed Mar 10, 2025 ΔOwn −1.4%

Stanton Marshall S. sold $39.8K of AORT, trimming their stake 1%.

−$39.8K
1,603 sh @ $25

Frequently asked questions

How is Stanton Marshall S.'s win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Stanton Marshall S.'s SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.